Fact CheckerSign in

NCT05485727Completed

Robotic Constraint Lokomat Training for Gait Rehabilitation in Patients with Stroke

Uses of Robotic Constraint Lokomat Training on Gait Rehabilitation in Saudi Females Patients with Stroke- a Randomized Controlled Study

Source: ClinicalTrials.gov · Last updated 3 Feb 2025

Brief summary (registry, in English)

The aim of this study is to investigate the effect of a lokomat training on gait performance in Saudi females with stroke. Design: A-Single blind randomized controlled trial. Methods: 28 females patients with stroke will be enrolled in this thesis (6-12 months after stroke); the patients will be randomly assigned into two equal groups of 14. Robotic-assisted gait training group (RG) will receive Lokomat gait training and conventional physiotherapy, while the other group is a control group (CG) will receive conventional physiotherapy. Duration of treatment will be 3 months. The lower limb joint range of motion, Balance, activities of daily living, walk speed, muscle tone of the lower limbs will be recorded before and after treatment and will compared between both groups.

Status (registry)
Completed
Study type
Interventional
Enrollment
28 (actual)
First submitted
1 Aug 2022
Start date
30 Mar 2022
Primary completion date
30 Sept 2023
Lead sponsor
Umm Al-Qura University
Diseases
Stroke
NCT number
NCT05485727

What you commit to

  • Study type: Interventional
  • Participants enrolled: 28
  • From 30 Mar 2022 to the primary completion date, 30 Sept 2023
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • cognitive impairment, behavioral disturbance, serious independent chronic disease likely to interfere with the ability to cooperate with the study, major contracture affecting muscles of the leg, Joint pathology of the lower limb other than that directly related to hemiplegia (eg, previous fractures, severe articular blocks); Patients under antispastic drug. Heart failure, unstable angina, uncontrolled hypertension peripheral arteriovenous occlusive disease. Neurogenic condition (other than stroke) affecting the gait pattern (e.g. ataxia, peripheral neuropathy, vertebrobasilar insufficiency and myelopathy), and patients with advanced osteoarthritis, and obesity (BMI \> 30)

Who the study is looking for

  • 28 stroke female patients, age ranged from 40- 65 years, Lower limb mild to moderate spasticity (Modified Ashwarth Scale 1+ to 3), be able to understand all instructions during intervention (Mini-Mental State Examination Score ≥24 points), \& be able to walk 10 m independently or under supervision

Age in the registry: 40 years to 65 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Faculty of Applied Medical Science - UQU
Coordinator of this site? Confirm its status
JeddahSaudi ArabiaUnknown status
UQU- KSA
Coordinator of this site? Confirm its status
JeddahSaudi ArabiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.